The global surgical sutures market size was valued at USD 4.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030. The COVID-19 pandemic led to a change in healthcare priorities. The healthcare providers mainly focused on the COVID-19 infected patients, while the government imposed complete lockdowns to avoid the spread of the virus. All the elective surgeries were postponed or kept on hold to avoid contracting the virus, leading to a shortage in demand for surgical sutures. Hence, a rapid drop in the sales of surgical sutures was observed in 2020 due to the outbreak of the COVID-19 pandemic.
The COVID-19 pandemic had a major negative impact on the market in 2020. With the economies opening up and countries returning to normalcy, surgical procedures are expected to be carried out at a much faster pace. Hospitals and ambulatory care centers are constantly strategizing to maximize the number of elective surgeries that are carried out. Healthcare providers are aiming to achieve this through telehealth assessment, screening tools, and optimized coordination tools.
Mobile apps allow the surgeons to provide information about the procedure, post-care instructions, and a checklist of items that need to be completed before showing up on the day of the procedure. This helps the healthcare providers to optimize procedures rooms and staff while helping patients receive the care they need. Similar strategies are helping the hospitals and ambulatory surgical centers to overcome the loss they have incurred during the pandemic and generate revenues at the pre-COVID growth rate. This has further helped the market to regain its growth in 2021.
A rise in lifestyle diseases due to the increasing adoption of a sedentary lifestyle is another factor majorly contributing to the market growth. Lifestyle diseases such as ischemic heart diseases, cerebrovascular diseases, orthopedic disorders, cancers, and mental illness are constantly rising, globally. This continuous rise in the prevalence of lifestyle diseases and growing demand for a higher number of surgical procedures are driving the market for surgical sutures.
The rise in healthcare expenditure by most countries and improving healthcare infrastructure in emerging economies are expected to promote patient footfall. In addition, technological advancement by key players helps to initiate more precise procedures, which increases the success rate of surgery. This is also leading to the growth of the market for surgical sutures.
The absorbable segment held the largest revenue share of over 55.0% in 2021 owing to its ability to provide temporary support to wounds till it heals and can withstand normal stress. Moreover, the demand for absorbable sutures is continuously rising, which can be attributed to their ability to degrade naturally. Due to this, key players in the market are investing in R&D activities, which is further expected to help the absorbable segment grow in the future.
Non-absorbable sutures accounted for a lower market share in comparison to absorbable sutures due to their inability to degrade or breakdown. These sutures are majorly used in the stressful internal environment where absorbable sutures are not able to fulfill the desired requirement. These sutures are basically used for slow-healing tissues or long-term closures.
The multifilament segment dominated the market for surgical sutures with a revenue share of over 55.0% in 2021. The multifilament segment is also expected to witness the fastest growth during the forecast period. This can be attributed to advantages associated with the multifilament segment such as better pliability, high tensile strength, and flexibility.
Monofilament sutures are difficult to handle and may cause crushing or crimping of the suture and lead to undesirable and premature suture failure during surgery due to their memory. The monofilament sutures are made up of materials such as monocryl, nylon, prolene, and polydioxanone. Although these sutures have a lower risk of infection, they have poor knot security. These factors are restricting the growth of monofilament sutures.
The others segment dominated the market for surgical sutures and held a revenue share of over 35.0% in 2021. The cardiovascular surgery segment held the second-largest revenue share in 2021. This is owing to the high incidence of cardiac diseases, the presence of sufficient experts in the field, supportive reimbursement scenarios, and advancement in diagnostics. This is leading to a significant rise in the number of cardiac surgeries, which in turn, is leading to an increase in the demand for surgical sutures over the forecast period.
The orthopedic surgery segment emerged as the third-largest application segment in 2021 and is expected to witness lucrative growth over the forecast period. This is due to the growing number of road accidents that are leading to a rise in the number of orthopedic injuries. According to the U.S. Department of Transportation, an estimated 20,160 people lost their lives in motor vehicle accidents in the first half of 2021.
The North American region dominated the market for surgical sutures in 2021 with a revenue share of over 40.0% owing to the presence of local and key players, high cost of sutures as compared to other regions, supportive reimbursement scenario, rising government programs, and developed healthcare infrastructure. Technological advancements and high domestic income are also the key factors that are contributing to the large revenue share of North America.
Asia Pacific is expected to witness the fastest growth during the forecast period. This is due to the growing geriatric population base that is more likely to go under surgery and increase in government spending on the healthcare infrastructure to meet the unmet needs in this region. China, India, and Japan are amongst the major markets in the Asia Pacific region. Increasing medical tourism in countries like India, Singapore, and Malaysia is another major factor that is driving the market towards exponential growth in this region.
The market is slightly consolidated with a few major players holding the majority revenue share. The key players are focusing on launching new products that will help them to conquer a strong position in the market. Moreover, they aim to carry out strategic initiatives such as partnerships, product launches, and collaborations to expand their geographical presence. In September 2020, Smith & Nephew launched its HEALICOIL KNOTLESS Suture Anchor. With this, the company aimed to grow its revolutionary line of advanced healing solutions for rotator cuff repair.
In August 2021, Ethicon US, LLC, which is a part of Johnson & Johnson, announced the launch of ProxiSure™ Suturing Device in the U.S. The device features Ethicon endomechanical, suture and curved needle technologies and is an advanced laparoscopic suturing device. In March 2017, Integra Lifesciences entered into a distribution agreement with Dr. Reddy’s Laboratories. According to the agreement, Dr. Reddy’s is responsible for marketing and distributing Suturable DuraGen and DuraGen Plus Dural Regeneration Matrices for use in patients in India. Some prominent players in the global surgical sutures market include:
Covidien
Ethicon US, LLC. (Johnson & Johnson Services, Inc.)
B. Braun Melsungen AG
Smith & Nephew
Integra Lifesciences
Peter Surgical
Internacional farmaceutica
CONMED CORPORATION
Sutures India Pvt. Ltd.
Report Attribute |
Details |
Market size value in 2022 |
USD 4.4 billion |
Revenue forecast in 2030 |
USD 6.5 billion |
Growth rate |
CAGR of 5.8% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2017 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million/billion & CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors & trends |
Segments covered |
Type, filament, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE |
Key Companies profiled |
Covidien; Ethicon US, LLC. (Johnson & Johnson Services, Inc.); B. Braun Melsungen AG; Smith & Nephew; Integra Lifesciences; Peter Surgical; Internacional farmaceutica; CONMED CORPORATION; Sutures India Pvt. Ltd. |
Customization scope |
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail of customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, region, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global surgical sutures market report based on type, filament, application, and region:
Type Outlook (Revenue, USD Million, 2017 - 2030)
Absorbable
Non-absorbable
Filament Outlook (Revenue, USD Million, 2017 - 2030)
Monofilament
Multifilament
Application Outlook (Revenue, USD Million, 2017 - 2030)
Ophthalmic Surgery
Cardiovascular Surgery
Orthopedic Surgery
Neurological Surgery
Others
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global surgical sutures market size was estimated at USD 4.2 billion in 2021 and is expected to reach USD 4.4 billion in 2022.
b. The global surgical sutures market is expected to grow at a compound annual growth rate of 5.8% from 2022 to 2030 to reach USD 6.5 billion by 2030.
b. North America dominated the surgical sutures market with a share of 40.3% in 2021. This is attributable to the adoption of technologically advanced medical devices, high domestic income, and local presence of major companies.
b. Some of the key players operating in the surgical sutures market include Medtronic, Ethicon, Smith & Nephew, Sutures India Pvt. Ltd., Internacional Farmacéutica., Péters Surgical, and Integra LifeSciences.
b. Key factors that are driving the surgical sutures market growth include an increase in the number of surgeries due to unhealthy lifestyles and aging populations, and initiatives, such as acquisitions and partnerships, undertaken by key companies for product development and distribution activities.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.